Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
European Journal of Cancer (Oxford, England : 1990)|October 1, 1996
Phase I/II trial of autologous activated macrophages in advanced colorectal cancerJ C Eymard, M Lopez, A Cattan, et al.
Radiation Oncology (London, England)|June 22, 2018
Adjuvant radiation therapy for malignant Abrikossoff's tumor: a case report about a femoral triangle localisationC Marchand Crety, C Garbar, G Madelis, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|February 4, 2010
[Update on the use of estramustin in metastatic prostate cancer]S Culine, L Drouet, J-C Eymard, et al.
British Journal of Cancer|March 5, 2002
Sequential or alternating administration of docetaxel (Taxotere) combined with FEC in metastatic breast cancer: a randomised phase II trialM Spielmann, M Tubiana-Hulin, M Namer, et al.
Prostate Cancer and Prostatic Diseases|October 15, 2014
Who dies from prostate cancer?A Patrikidou, Y Loriot, J-C Eymard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 17, 2007
Randomized phase II study of docetaxel plus estramustine and single-agent docetaxel in patients with metastatic hormone-refractory prostate cancerJ-C Eymard, F Priou, A Zannetti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2011
Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma?R Sabatier, J C Eymard, J Walz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 6, 2014
Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trialK Fizazi, G Gravis, A Flechon, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 10, 1998
Simultaneous high-dose external irradiation and daily cisplatin in unresectable, non-metastatic adenocarcinoma of the pancreas: a phase I-II studyT D Nguyen, S Theobald, P Rougier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
Translational studies within the TAMRAD randomized GINECO trial: evidence for mTORC1 activation marker as a predictive factor for everolimus efficacy in advanced breast cancerI Treilleux, M Arnedos, C Cropet, et al.
Pageof 3